TABLE 1.
Participant characteristics at screening for those randomized to treatment1
| Control, n = 51 | Almond, n = 56 | |
|---|---|---|
| Age, y | 56.0 ± 10.7 | 56.3 ± 10.3 |
| Sex, M/F, n | 15/36 | 17/39 |
| Ethnicity (black/South Asian, Southeast Asian, and Middle Eastern/Far East/white/other), n | 2/6/2/34/7 | 9/7/3/34/3 |
| Cardiometabolic score | 4.2 ± 2.1 | 4.5 ± 2.0 |
| BMI, kg/m2 | 26.7 ± 4.5 | 27.3 ± 4.4 |
| Waist circumference, cm | 93.3 ± 12.5 | 93.6 ± 12.5 |
| Body fat, % | 32.7 ± 8.5 | 34.4 ± 8.4 |
| cSBP, mmHg | 124.4 ± 15.1 | 126.2 ± 17.6 |
| cDBP, mmHg | 80.6 ± 7.7 | 83.8 ± 10.8 |
| Glucose, mmol/L | 5.1 ± 0.6 | 5.1 ± 0.5 |
| TC, mmol/L | 5.6 ± 1.2 | 5.6 ± 1.0 |
| TAG, mmol/L | 1.2 ± 0.5 | 1.2 ± 0.6 |
| LDL, mmol/L | 3.5 ± 1.0 | 3.4 ± 0.9 |
| HDL, mmol/L | 1.6 ± 0.5 | 1.6 ± 0.5 |
| TC:HDL | 3.6 ± 0.9 | 3.7 ± 1.1 |
1Values are means ± SD or categorical totals. Ethnicity was determined by self-reporting. Chi-square test was used to examine whether there were differences in sex and ethnicity. Independent t test was used to examine whether there were differences in other characteristics. There were no differences between groups for any of the parameters included in this table. cDBP, clinical diastolic blood pressure; cSBP, clinical systolic blood pressure; TAG, triglyceride; TC, total cholesterol.